Skip to Main Content

Paper Details

Introduction or Discontinuation of Additional Risk Minimisation Measures During the Life Cycle of Medicines in Europe.
Drug Saf
6
2021
Author NameAffiliation
Miriam C J M SturkenboomUniversity Medical Centre Utrecht
  • 1 - 1

Datasets

Release 1.2